Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
cbdMD, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
YCBD
NYSE American
2834
www.cbdmd.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for cbdMD, Inc.
cbdMD, Inc. to Host Conference Call to Discuss December 31, 2024 First Quarter of Fiscal Year 2025 Results
- Feb 7th, 2025 10:26 pm
cbdMD Announces It Has Fully Satisfied Its Notes
- Jan 15th, 2025 3:30 pm
cbdMD Announces Additional Conversions of Its Convertible Notes
- Jan 8th, 2025 10:22 pm
cbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standard
- Jan 3rd, 2025 9:44 pm
cbdMD Announces Company's CEO Joins the Board of Directors
- Dec 23rd, 2024 8:52 pm
cbdMD Generates $19.1 Million in Year Over Year Reduction in Net Loss Improvement
- Dec 18th, 2024 9:08 pm
cbdMD, Inc. to Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results
- Dec 18th, 2024 4:04 pm
cbdMD, Inc. Reschedules Earnings Release and Conference Call
- Dec 17th, 2024 9:42 pm
cbdMD Launches Herbal Oasis Social Tonics, Hemp-Derived THC Seltzers
- Nov 14th, 2024 7:26 pm
cbdMD, Inc. Announces Acceptance of Compliance Plan by NYSE American
- Aug 26th, 2024 8:25 pm
cbdMD Delivers on Sequential Revenue Growth and Positive Net Income for Q3 2024
- Aug 14th, 2024 8:10 pm
cbdMD, Inc. to Host Conference Call to Discuss Third Quarter of Fiscal 2024 Results
- Aug 5th, 2024 3:03 pm
cbdMD Announces Publication of Human Clinical Trial Data
- Jun 27th, 2024 3:45 pm
cbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
- Jun 7th, 2024 9:36 pm
cbdMD Unveils ATRx Labs Premium Mushroom Line at GNC, Expanding cbdMD's Natural Wellness Solutions
- May 24th, 2024 2:03 pm
cbdMD Launches Max Chill Dragon Fruit D9 Gummies: Your Go-To Relaxation Blend for the Summer
- May 16th, 2024 2:37 pm
cbdMD Reports Second Quarter Results
- May 15th, 2024 8:09 pm
cbdMD, Inc. to Host Conference Call to Discuss Second Quarter of Fiscal 2024 Results
- May 13th, 2024 3:20 pm
cbdMD Reduces Year over Year Net Loss from Operations by $3.0 Million
- Feb 13th, 2024 9:10 pm
Scroll